Verismo Therapeutics (@verismotx) 's Twitter Profile
Verismo Therapeutics

@verismotx

Verismo is a pioneer in KIR-CAR technology. The KIR-CAR platform technology is developed specifically for solid tumors, an area of high unmet medical need.

ID: 1395047842864111619

calendar_today19-05-2021 16:06:05

20 Tweet

61 Followers

37 Following

Verismo Therapeutics (@verismotx) 's Twitter Profile Photo
Verismo Therapeutics
@verismotx

2 years ago

FDA grants Verismo Therapeutics Fast Track designation for SynKIR-110, a potential new treatment for pleural mesothelioma, a rare and aggressive cancer. We look forward to advancing SynKIR-110 in our Phase 1 trial to reach patients sooner. #CART #Mesothelioma #VerismoTherapeutics

FDA grants Verismo Therapeutics Fast Track designation for SynKIR-110, a potential new treatment for pleural mesothelioma, a rare and aggressive cancer. We look forward to advancing SynKIR-110 in our Phase 1 trial to reach patients sooner. #CART #Mesothelioma #VerismoTherapeutics